Consolidated Statements of Operations (Unaudited) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Product revenues	$ 7,105	$ 7,697	$ 20,540	$ 20,415
Service revenues	8,906	6,262	22,796	12,277
Total revenues	16,011	13,959	43,336	32,692
Cost of sales	5,912	5,210	16,425	10,890
Gross profit	10,099	8,749	26,911	21,802
Operating expenses:
Selling, general and administrative	6,441	6,487	18,691	18,074
Research and development	2,247	2,399	6,553	6,524
Change in fair value of contingent consideration	3,776	878	4,176	933
Total operating expenses	12,464	9,764	29,420	25,531
Operating loss	(2,365)	(1,015)	(2,509)	(3,729)
Interest expense, net	(31)	(94)	(275)	(203)
Other income (loss), net	(22)	30	(23)	(37)
Loss before taxes	(2,418)	(1,079)	(2,807)	(3,969)
Income tax benefit (expense), net	(137)	32	(12)	(72)
Net loss	(2,555)	(1,047)	(2,819)	(4,041)
Less: Net income attributable to Non-controlling interests	5	30	36	38
Net loss attributable to ChyronHego Shareholders	$ (2,560)	$ (1,077)	$ (2,855)	$ (4,079)
Net loss per share attributable to ChyronHego shareholders - basic (in Dollars per share)	$ (0.07)	$ (0.04)	$ (0.08)	$ (0.17)
Net loss per share attributable to ChyronHego shareholders - diluted (in Dollars per share)	$ (0.07)	$ (0.04)	$ (0.08)	$ (0.17)
Weighted average shares outstanding:
Basic (in Shares)	36,754	30,236	34,341	23,576
Diluted (in Shares)	36,754	30,236	34,341	23,576